We narrowed to 6,491 results for: cki

#132090

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Nov. 21, 2019

Industry, Academic Institutions, and Nonprofits

#132042

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Nov. 4, 2019

Industry, Academic Institutions, and Nonprofits

#213172

CIRTS RNA targeting system for targeted knockdown in neurons. CIRTS-Calm3 and Gas5 guide RNA is expressed under human Syn1 and U6 promoter, respectively.

Timothy Bredy

Liau et al Nat Commun. 2023 Nov 22;14(1):7616. doi:

Feb. 28, 2024

Academic Institutions and Nonprofits only

#132158

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Oct. 22, 2019

Industry, Academic Institutions, and Nonprofits

#161031

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#185012

Bacterial Expression of 6xHis CBX5 (HP1a) mCherry Fusion Protein

Denes Hnisz

Asimi et al Nat Genet. 2022 Aug;54(8):1238-1247. doi

June 16, 2022

Academic Institutions and Nonprofits only

#79797

Insulin receptor isoform A with a inter-domain EBFP2 tag at extracellular region (between furin-like domain and transmembrane domain). For imaging insulin receptor trafficing.

James Johnson

Boothe et al Mol Metab. 2016 Feb 10;5(5):366-78. doi:

Aug. 5, 2016

Industry, Academic Institutions, and Nonprofits

#161162

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#131945

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Oct. 17, 2019

Industry, Academic Institutions, and Nonprofits

#179454

Lentiviral Crispr/Cas9 plasmid targeting hPER2 at C-terminus to generate C-terminal knock-in

Achim Kramer

Gabriel et al Nat Commun. 2021 Jun 18;12(1):3796. doi:

March 29, 2022

Academic Institutions and Nonprofits only